Sarepta Elevidys Shipments - Search News

Order byBest matchMost fresh

News

Sarepta falls

· 13h · on MSN

Sarepta Changes Course, Agrees to Pause Elevidys Shipments

Sarepta Therapeutics Inc. announced that the company plans to temporarily pause all shipments of its gene therapy to treat Duchenne muscular dystrophy, Elevidys, in a reversal of its prior stance.

Continue reading

Sarepta Concedes to FDA Request, Suspends US Shipments of Elevidys

Sarepta falls after gene therapy maker pauses Elevidys shipments in US

2hon MSN

Sarepta Therapeutics stock sinks further Tuesday after halting shipment of bestselling drug Elevidys

Sarepta stock tanked Friday after a new patient death was uncovered, spurring an FDA request to halt shipments of an unrelated drug.

Pharmalittle: We’re reading about Sarepta conceding to the FDA, the U.S. transplant system, and more

Sarepta Therapeutics reversed course and agreed to halt all shipments of Elevidys, its gene therapy for Duchenne muscular ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results